Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.9400 (1.2%) ($87.4280 - $90.4800) on Thu. May. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 64 | Latest Price | $89.9400(1.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(51%) SPLV(37%) VYM(35%) DIA(34%) IVE(33%) | Factors Impacting ABBV price | ABBV will decline at least -1.73% in a week (0% probabilities). VIXM(-26%) UUP(-9%) VXX(-7%) TLT(-4%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -0.1 () | Intraday Trend | 2.6% | | | |
|
5 Day Moving Average | $88.23(1.94%) | 10 Day Moving Average | $86.24(4.29%) | 20 Day Moving Average | $84.59(6.32%) | To recent high | -5.3% | To recent low | 39.4% | Market Cap | $158.68b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |